Bilberry is a low-risk, low-cost berry extract whose pigments may modestly improve cholesterol, long-term blood sugar, and eye strain from heavy screen use — mainly in people who already have raised levels. The famous night-vision claim is not supported. Best seen as a minor add-on, not a longevity cornerstone. (Full Review)

Protocol

Dose

80–160 mg

Fruit extract, once or twice daily

Form

25–36% anthocyanins

Standardized fruit extract, not leaf

Timing

With meals

Split twice daily for sustained levels

Time to effect

Cholesterol

4+ weeks

Often longer

Blood Sugar

4+ weeks

HbA1c over ~3 months

Eye Strain

4–12 weeks

From heavy screen use

Benefits

Medium: Improved blood lipid profile; better glycemic control in dysglycemia

Low: Relief of eye strain and focusing fatigue; reduced inflammatory markers; microcirculatory and venous support

Speculative: Cognitive and mood support; anticancer and cellular-protective effects; skin aging and antioxidant capacity

Contraindications

Bleeding disorders

Scheduled surgery (discontinue high-dose extract at least 2 weeks prior)

Pregnancy or breastfeeding (medicinal doses)

Poorly controlled diabetes on glucose-lowering drugs without monitoring

Key Interactions

Anticoagulant and antiplatelet drugs (warfarin, apixaban, rivaroxaban, clopidogrel, aspirin)

Antidiabetic drugs (insulin, sulfonylureas, metformin)

NSAIDs (ibuprofen, naproxen)

Other blood-sugar-lowering supplements (berberine, cinnamon, alpha-lipoic acid)

Other anthocyanin- or flavonoid-rich supplements (blackcurrant, grape seed extract, pine bark extract) and fish oil

Risk & Side Effects

Low: Mild gastrointestinal upset; theoretical increased bleeding risk; possible effect on blood sugar in diabetics

Speculative: Leaf toxicity at high or prolonged doses; allergic reactions

Monitoring

Marker	Target	Why
LDL cholesterol	< 100 mg/dL (often < 70 for higher-risk)	Primary lipid target bilberry may modestly affect
HDL cholesterol	> 50 mg/dL	Some trials report HDL increase
HbA1c	< 5.4% (conventional normal < 5.7%)	Average blood sugar over ~3 months; main glycemic endpoint
Fasting glucose	70–85 mg/dL (conventional normal < 100)	Detects additive glucose lowering, especially with diabetes drugs
hs-CRP	< 1.0 mg/L	Tracks the anti-inflammatory effect, if any

Cadence: Re-check relevant labs at ~8–12 weeks, then every 6–12 months if continued long term

Qualitative Assessment

Subjective eye comfort and reduced eye fatigue during prolonged screen use
Perceived visual clarity or focusing comfort at end of day
General energy and well-being
Absence of digestive upset (a tolerability check)

Bilberry for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment